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The thymus is the site of T cell maturation. Notch receptors (Notch1-4) and ligands (DLL1-3 and Jagged1-2)
constitute one of several pathways involved in this process. Our data revealed differential constitutive
expression of Notch genes and ligands in T lymphocytes and thymic dendritic cells (tDCs), suggesting their
participation in human thymocyte maturation. nTreg analyses indicated that the Notch components
function in parallel to promote maturation in the thymus.
& 2016 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The thymus is a privileged and indispensable site for the gen-
eration and maturation of T cells in vivo, as this microenvironment
induces and supports lineage commitment, differentiation, and
survival of thymus-seeding cells. Indeed, the thymus is both where
the T cell repertoire is generated and where T cells are shaped by
positive and negative selection, giving rise to a broad functional
MHC-restricted naïve TCR αβ repertoire [1].
T cell progenitors derived from hematopoietic stem cells
migrate from the bone marrow and undergo development in the
thymic environment to generate the T cell lineage. Notch signaling
is one of several pathways involved in promoting T lineage com-
mitment and maturation [2]. Notch receptors and their ligands are
a family of trans membrane proteins involved in a variety of cell
fate decisions that affect the developmental functions of many
organs and systems, including hematopoiesis and the immunen open access article under the CC
Investigation in Dermatology
– USP, São Paulo, Brazil.
).system. Mammalian genomes encode four Notch receptors (Notch
1–4, which are homologous to the single Notch receptor in Dro-
sophila) and ﬁve ligands (Delta-like 1, 3, and 4 and Jagged 1 and 2,
which are homologous to the Delta and Serrate ligands in Droso-
phila) [3]. The best established function for Notch signaling in the
hematopoietic system is the essential role it plays in promoting
T lineage commitment and maturation [4].
T lineage speciﬁcation is mediated exclusively by Notch 1, and
induced deletion of Notch 1 in hematopoietic progenitors results in
a complete block of T cell development and the ectopic differ-
entiation of immature B cells in the thymus [5]. Notch receptor-
ligand interactions communicate signals between neighboring cells
via highly conserved signaling mechanism activated through the
interaction of the Notch receptor with its cognate ligand [6]. This
pathway is initiated when Notch-ligand engagement induces two
successive proteolytic cleavages, the second of which is mediated by
a presenilin-containing complex exhibiting γ-secretase activity that
releases the Notch intracellular domain (NICD). This activated form
of Notch translocates to the nucleus where it binds to the CSL
protein (also known as RBPJ, an important nuclear mediator of
Notch signaling that is similar to the DNA-binding protein found inBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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activators [7].
Each Notch receptor interacts with a speciﬁc Notch ligand in a
context-dependent manner. Numerous studies have identiﬁed
transcripts for all Notch ligands in the thymus [8]. Members of the
Delta-like family appear to be crucial for T lineage commitment
and maturation. A report by Mohtashami and Zúgñiga-Pﬂücker [9]
highlighted the importance of Delta-induced signals by demon-
strating that the loss of DLL1 and DLL4 expression led to the
inability of fresh, ex vivo thymic stromal monolayers to support T
lineage speciﬁcation following disruption of their three-
dimensional organization. In contrast, the inactivation of the
DLL1 ligand does not block T cell development, suggesting a
redundant role for this and other DLL ligands, such as DLL4 [4].
These data suggest that Notch1 signaling in early thymocyte pro-
genitors is restricted to DLL4 in the thymus [2].
T regulatory cells of the CD4þCD25þFOXP3þphenotype, also
known as natural T regulatory cells (nTreg), are generated in the
thymus as a speciﬁc T cell lineage and are critical for the main-
tenance of immune homeostasis and the suppression of naturally
occurring self-reactive T cells [10]. The generation and maturation
of this speciﬁc T cell lineage involve particular and complex pro-
cesses within the thymus, and many signaling pathways partici-
pate in these processes. Ou-Yang and colleagues (2008) demon-
strated that Notch signaling modulates the Foxp3 promoter
through a RBPJ- and HES-1-dependent mechanism (notch target
genes with transcriptional repressor functions that negatively
regulate gene transcription) [11]; however, further investigations
will be required to determine the components of this pathway (in
the context of Notch signaling) that are involved in the processes
of nTreg commitment, maturation, and differentiation.
Within the thymic medullary region, groups of epithelial cells,
termed Hassal's corpuscles, have been shown to play a critical role
in the maturation of developing thymocytes [12] and the genera-
tion of nTreg [13]. Human Hassal's corpuscles express thymic
stromal lymphopoietin (TLSP), which activates thymic dendritic
cells (tDC) to express high levels of CD80 and CD86. Once acti-
vated, tDCs induce the proliferation and differentiation of
CD4þCD8-CD25-thymic T cells into CD4þCD25þFOXP3þcells,
suggesting that tDCs play a crucial role in dendritic cell-mediated
secondary positive selection of nTreg [13].
In this study, we investigated the expression of the Notch
receptor and ligand genes in immature thymocytes, nTreg and
tDCs to evaluate the potential involvement of this pathway in the
maturation of T lymphocyte and nTreg cells in the human thymus.2. Materials and methods
2.1. Patient samples
Thymic tissues were obtained from 10 patients who underwent
corrective cardiac surgery at the Hospital do Coração (HCor), SP,
Brazil ( mean 3.24 years). Each sample where analyzed in three
independent experiments. The patients did not exhibit signs of
immunodeﬁciency. The ethics committees at the Hospital do
Coração and the School of Medicine at the University of São Paulo
approved this study. Informed consent was obtained from the
parents of all children.
2.2. Thymus tissue dissociation, cell isolation, and storage
Thymocytes and tDCs were released from the tissue samples
using enzymatic dissociation. The thymus was cut into small
fragments and added to 50-mL propylene conical centrifuge tubes.
Next, an enzymatic solution (10 mL) containing RPMI pre-warmedto 37 °C, 0.5 mg/mL collagenase A, 0.02 mg/mL DNAse I (Roche
Diagnostics, Mannheim, Germany), and 5% FBS was added, and
incubation was performed for 10 min at 37 °C under continuous
agitation. The digested fragments were homogenized gently and
ﬁltered through a plastic sieve with a 70-μM mesh screen (Cell
Strainer, BD Falcon, CA, USA) to remove aggregates and stromal
material. The resultant cell suspensions were washed twice with
wash buffer 1 (50 mL RPMI [Gibco – Life Technologies, Grand
Island, NY, USA]) pre-warmed to37 °C, 0.1 mg/mL collagenase A
[Roche Diagnostics, Mannheim, Germany], and 0.02 mg/mL DNase
I [Roche Diagnostics, Mannheim, Germany]), followed by cen-
trifugation at 540 g for 5 min. Next, the pelleted cells were
resuspended in a second wash buffer (50 mL cold PBS, 5 mM EDTA
[Sigma Aldrich, Saint Louis, MO, USA], 0.02 mg/mL DNase I, and 5%
FBS [Gibco – Life Technologies, USA]) and centrifuged at 540 g for
5 min. The pelleted cells were resuspended immediately in RPMI,
and the low-density fraction was collected following centrifuga-
tion through Ficoll-Paque (GE Healthcare Bio Science, Uppsala,
Sweden) at 540 g for 20 min. The cells were washed twice using
RPMI and centrifuged at 1500 rpm for 10 min. The thymic cells
were frozen and stored at 80 °C until use.
2.3. Flow cytometry and puriﬁcation of thymic populations
Thawed cells were re suspended in pre-warmed RPMI, the
number of cells per tube was adjusted, and the cells were sub-
jected to ﬂuorescence staining. To characterize cells populations in
the human thymus, thymocytes were stained with human anti-
CD3 PE-Cy7,-CD4 FITC or APC,-CD8 PE,-CD11cPE and -CD25 PE or
FITC antibodies (BD Pharmingen, New Jersey, USA) and the cell
populations were sorted into CD3-CD4-CD8-, CD4þCD8þ , CD4-
CD8þ , CD4þCD8-, CD3þCD4þCD8-CD25high, and CD11cþsub-
sets using a FACSAria II ﬂow cytometer (BD Pharmingen, New
Jersey, USA). The purity of all sorted cell subsets was greater
than 97%.
2.4. RNA puriﬁcation and preparation of cDNA
After cell sorting, total RNA from the sorted populations was
isolated using the RNeasy Plus mini and micro kits (QIAGEN, Hil-
den, Germany) and was retro transcribed using Sensiscript (QIA-
GEN, Hilden, Germany) in accordance with the manufacturer's
instructions.
2.5. Real-time PCR
The NOTCH1, NOTCH2, NOTCH3, DLL1, DLL3,DLL4, JAG1, JAG2,
and FOXP3 genes were ampliﬁed using speciﬁc TaqMans Gene
Expression Assays and SYBR Green ﬂuorescent dye (Applied Bio-
systems, California, USA) with an ABI 7600 SDS platform (Applied
Biosystems, California, USA) in accordance with the manu-
facturer's instructions. The NOTCH4 gene was not evaluated in any
of the puriﬁed subsets of cells. The GAPDH housekeeping gene was
used for normalization. HEK cells were used as a reference for
gene expression because they express all evaluated genes (NIH,
Bethesda, MD, USA). All the RT-PCR reactions were performed
using controls for exogenous contamination and genomic DNA
contamination. Gene expression was calculated as 2-ΔCt, which
corresponds to the Ct value of the target gene in a population
normalized using the Ct value of the housekeeping gene (GAPDH)
in the same population and was expressed as the mean7standard
error. To perform relative gene analysis, we calculated 2ΔΔCt in
accordance with the method of Livak et al. [14], and the data were
expressed as the means7standard errors. The following probes
were used: NOTCH1 (Hs01062014), NOTCH2 (Hs01050702),
NOTCH3 (Hs01128541), JAG1 (Hs01070032), JAG2 (Hs00171432),
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Fig. 1. Expression of Notch receptor and ligand genes in thymocyte subsets. (A) Total thymocytes were sorted into CD4-CD8-, CD4þCD8þ , CD4-CD8þ , and CD4þCD8-
populations. (B-H) Gene expression of Notch receptors and ligands in total RNA isolated from puriﬁed thymocyte subsets and from HEK cells (positive controls). The bars
represent the means7SD, *po0.05 in comparison to an indicated subset (n¼10).
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5834) all from Applied Biosystems, California, USA. The DLL4 pri-
mers 50-CAGAGTGTCGGATATCAGCG-30 and 50-CCTGCCTTATACCTC-
CGTG-30 (Applied Biosystems, California, USA) were used.
2.6. Statistical analysis
Comparisons of the expression of genes among the evaluated
groups were performed using one-way ANOVA, Tukey's post-test
(to compare all column pairs), and the Bonferroni method (to
compare selected pairs of columns). Statistical signiﬁcance was
deﬁned as a p-Value o0.05 using GraphPad Prism software
(California, USA).3. Results
3.1. Characterization of thymic populations and notch receptor and
ligand gene expression in developing lymphocytes
We analyzed suspensions of total thymocytes and character-
ized the main developmental stages of T cells within the thymus
(Fig. 1A). Next, we investigated the expression of the Notch
receptor and ligand genes NOTCH1, NOTCH2, NOTCH3, JAG1, JAG2,
DLL1, DLL3 and DLL4 in these populations using HEK cells as a
reference. All Notch receptors and ligands were expressed in each
subset, with the exception of the DLL3 gene (Fig. 1B-H). The
NOTCH1 gene was expressed at a higher level in the CD4-CD8-
subset than the CD4þCD8-subset (Fig. 1B), and the JAG2 gene
exhibited higher expression in the CD4þCD8þsubset than the
CD4þCD8-cell subset (Fig. 1H). The NOTCH3, DLL1, DLL4, and JAG1
genes exhibited similar expression levels among thymocyte sub-
sets (Fig. 1D-G).CD
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Fig. 2. Expression of FOXP3 and Notch receptor and ligand genes in nTreg. (A) Expre
(B) Expression of Notch receptor and ligand genes in nTreg. (C) Relative expression of Not
(D) Relative expression of Notch receptor and ligand genes in nTreg using theCD4þCD8
between thymocyte subsets (n¼10).3.2. Characterization of nTreg cells and evaluation of notch receptor
and ligand gene expression
We isolated thymic nTreg cells with the phenotype
CD3þCD4þCD8-CD25high; these cells represented 2.1670.4% of
the total thymocytes and expressed the FOXP3 gene at higher
levels compared to the other studied populations (Fig. 2A).
After characterizing the nTregs, we evaluated the expression of
the NOTCH1,2, and 3; DLL1,3 and 4;and JAG1 and 2 genes
in this cell subset. The nTreg cells expressed all of these Notch
receptor and ligand genes, with the exception of the DLL3 gene.
The expression levels of the evaluated Notch receptors and ligands
were not signiﬁcantly different from one another (Fig. 2B). In
comparison to the initial stage of thymocyte development (CD4-
CD8-phenotype), nTreg cells demonstrated increased expression of
the NOTCH1, NOTCH2, DLL4, and JAG1 genes but lower expression
of the NOTCH3, DLL1, and JAG2 genes (Fig. 2C). Interestingly, when
nTreg cells were compared to cells at the later stage of develop-
ment with a non-regulatory phenotype (CD4þCD8-), we observed
increased expression of the NOTCH1, NOTCH2, NOTCH3, DLL4,and
JAG1 genes and similar levels of DLL1 and JAG2 gene expression
(Fig. 2D).
3.3. Characterization of notch receptor and ligand expression in tDCs
Finally, we characterized tDCs by ﬂow cytometry using the
CD11c molecule. After cell sorting, we found that this subset
represented 3.170.4% of the total thymocyte population. The
expression of the DLL4 ligand was higher than those of the other
Notch receptor and ligand genes in tDCs (Fig. 3). In addition, the
expression of the JAG2 gene was higher than that of the Notch
receptor and ligand genes (with the exception of DLL4), and lowerNO
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Fig. 3. Gene expression of Notch receptors and ligands in tDCs. Expression of Notch
receptor and ligand genes in tDCs. The bars represent the means7SD (n¼10),
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detected in tDCs (Fig. 3).4. Discussion
Notch signaling is involved in regulating the TCR-αβ/γδ lineage
decision [15]. Several studies have demonstrated that Notch
receptors and ligands are expressed during different phases of T
cell maturation in rodents [16–18], although the situation in
humans is less clear. Therefore, we evaluated the expression of
Notch receptor and ligand genes in subsets of developing lym-
phocytes, nTreg cells, and tDC cells in the human thymus.
The frequencies of the lymphocyte subsets at different devel-
opmental stages were similar to those previously described in the
literature [19,20]. In the CD4-CD8-subset, we observed an
increased level of NOTCH1 gene expression compared to the
CD4þCD8-subset, which was consistent with previous observa-
tions in mice [3]. In the human thymus, a previous report by Van
de Walle et al., 2009 revealed that NOTCH1 was more highly
expressed in CD34þcells, with or without CD1 co-expression,
compared to TCRαβþ thymocytes. This result is consistent with
our results; our CD4-CD8-subset is equivalent to CD34þthymo-
cytes and our CD4þCD8-subset is included in TCRαβþ cells.
Therefore, NOTCH1 gene expression seems to contribute to T
lineage commitment mainly at immature stages, as suggested by
Maillard et al. [3].
We observed similar expression of the NOTCH2 gene between
TCRαβþ cells, which differs from published reports in mice
demonstrating that this receptor is expressed at higher levels
during early stages of maturation, similar to the CD4-CD8-
population [21]. Van de Walle et al. previously examined the
NOTCH2 gene in human thymus, and also observed similar
expression between CD4þCD8þCD3-and TCRαβþ subsets [22].
Therefore, these data suggest that the NOTCH2 gene is
expressed not only in the earlier stages of T cells development but
also in mature single positive lymphocytes. Because this receptor
is similar to Notch1 [17], our data suggest that NOTCH2 gene
expression may be involved in all stages of CD4þand CD8þT cell
maturation.
The CD4þCD8-population expressed lower levels of the
NOTCH1 gene in comparison to the CD4-CD8-subset, a feature alsoobserved in mice [23]. Nevertheless, in the CD4þCD8-subset, we
determined that the JAG2 gene was expressed at a lower level in
comparison to CD4þCD8þthymocytes. Studies using a co-culture
system of human CD34þCD38-lin- CB cells (uncommitted CB
cells) with Jagged2-transduced OP9 stromal cells found that these
conditions supported the development of early CD7þCD1þ-
committed T cell precursors and their further development into
CD4þCD8βþdouble-positive thymocytes and CD3þTCRαβþ cells
[15]. Therefore, our analysis demonstrating constitutive JAG2 gene
expression at lower levels among CD4þCD8-lymphocytes com-
pared to CD4þCD8þthymocytes suggests that this gene may be
involved in CD4þT cell lineage commitment or may represent a
consequence of this type of maturation.
Furthermore, we demonstrated that the DLL1 gene, although at
low levels, seems to be expressed constitutively in the CD4þCD8-
population of thymocytes in humans; this was not speciﬁcally
conﬁrmed at the protein level, but it has not been demonstrated
previously in mice or humans [2]. This result suggests that this
ligand may play an important role in the later stages of T lympho-
cyte maturation, primarily for CD4þT lymphocyte development.
This study is also the ﬁrst to demonstrate expression of the
DLL4 gene in thymocyte populations, although this ligand has been
shown to be expressed preferentially by thymic stromal cells in
mice [3,24]. In mice, the initial steps of T lineage maturation
require DLL4 signaling via the Notch1 receptor [25], which,
according to our data, may also occur during the later stages of
human T lymphocyte development.
Previous reports in the literature have demonstrated the
expression of Notch receptor and ligand genes in human nTreg
[22]; accordingly, we found that nTreg expressed all the Notch
receptor and ligand genes evaluated.
Of the Notch receptors and ligands evaluated in this study, the
DLL4 gene appeared to be more highly expressed in nTreg; how-
ever, statistical analysis demonstrated that expression of this
ligand was not different from that of the other Notch receptor and
ligand genes.
When nTreg were compared to the CD4þCD8-population, we
observed that NOTCH1 gene expression was increased seven-fold,
and NOTCH2 gene expression was increased three-fold in nTreg.
These data suggest that nTreg exhibit a signiﬁcant alteration in
NOTCH1 and NOTCH2 gene expression levels during maturation
compared to CD4þnon-regulatory T cells in the thymus. Notch1
and Notch2 receptors play similar roles during the maturation of
developing thymocytes [17], but their roles in nTreg maturation
have not been described.
tDCs play a major role in T lymphocyte maturation, principally
in the generation of nTreg cells [13,19]. This role is mediated
mainly by cell-to-cell contact; therefore, the expression of Notch
receptor and ligand genes in these cells suggests the involvement
of the Notch pathway in T lymphocyte maturation in the human
thymus.5. Conclusion
Taken together, our data suggest that changes in the expression
of Notch ligands and receptors play a role in the spontaneous
lymphocytes maturation in the human thymus. Furthermore, in
this study we uncover the possible involvement of Notch signaling
in human nTreg maturation.Conﬂict of interests
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